By: Stephanie Kawecki On: April 24, 2026 In: Foldax, Portfolio News

Foldax is addressing a key challenge recently highlighted by The Wall Street Journal: as minimally invasive TAVR procedures expand,...

Read more
By: Stephanie Kawecki On: April 23, 2026 In: Foldax, Portfolio News

Foldax Inc. was recently highlighted among a select group of companies shaping the next generation of heart valve replacement....

Read more
By: Stephanie Kawecki On: April 23, 2026 In: MixComm, Portfolio News

Sivers Semiconductors is supplying lasers and optical amplifiers to a strategic LiDAR customer, with production expected to ramp in...

Read more

Actuate Therapeutics announced clinical trial results published in Nature Medicine showing that adding elraglusib to chemotherapy doubled 12-month survival rates in patients with...

Read more

Hypersonic design used to take years — now we’re seeing dramatically shorter timelines. Aerospace firms like Specter Aerospace are...

Read more
By: Stephanie Kawecki On: April 1, 2026 In: MixComm, Portfolio News

Sivers Semiconductors has announced the availability of its Daybreak 5G/6G beamforming ICs designed for emerging FR3 applications, a frequency...

Read more
By: Stephanie Kawecki On: March 20, 2026 In: Portfolio News, Provivi

Provivi is expanding its reach in Europe through a new distribution agreement with Andermatt Group focused on sustainable crop...

Read more
By: Stephanie Kawecki On: March 20, 2026 In: MixComm, Portfolio News

Sivers Semiconductors has partnered with O-Net and Enablence Technologies to develop external light sources for next-generation AI data centers....

Read more

Actuate Therapeutics has launched a new strategic research initiative exploring combination therapies with its lead drug, elraglusib. Read more...

Read more
By: Stephanie Kawecki On: March 12, 2026 In: MixComm, Portfolio News

Sivers Semiconductors announced that a strategic LiDAR customer has incorporated its photonics technology across their sensing platforms and plans...

Read more